Wealth Enhancement Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38M | Buy |
82,641
+2,452
| +3% | +$1.13M | 0.06% | 275 |
|
|
2025
Q1 | $38.9M | Hold |
80,189
| – | – | 0.07% | 249 |
|
|
2024
Q4 | $32.3M | Sell |
80,189
-21,702
| -21% | -$8.74M | 0.06% | 281 |
|
|
2024
Q3 | $47.4M | Buy |
101,891
+16,279
| +19% | +$7.57M | 0.1% | 197 |
|
|
2024
Q2 | $40.1M | Buy |
85,612
+3,576
| +4% | +$1.68M | 0.1% | 208 |
|
|
2024
Q1 | $34.3M | Buy |
82,036
+7,061
| +9% | +$2.95M | 0.09% | 220 |
|
|
2023
Q4 | $30.5M | Buy |
74,975
+27,386
| +58% | +$11.1M | 0.09% | 213 |
|
|
2023
Q3 | $16.5M | Buy |
47,589
+37,677
| +380% | +$13.1M | 0.05% | 314 |
|
|
2023
Q2 | $3.49M | Buy |
9,912
+134
| +1% | +$47.2K | 0.04% | 154 |
|
|
2023
Q1 | $3.08M | Buy |
9,778
+84
| +0.9% | +$26.5K | 0.04% | 168 |
|
|
2022
Q4 | $3.1M | Sell |
9,694
-3,525
| -27% | -$1.13M | 0.04% | 149 |
|
|
2022
Q3 | $3.9M | Buy |
+13,219
| New | +$3.9M | 0.06% | 131 |
|
|
2022
Q2 | – | Sell |
-22,874
| Closed | -$6.15M | – | 372 |
|
|
2022
Q1 | $6.15M | Buy |
22,874
+831
| +4% | +$223K | 0.08% | 119 |
|
|
2021
Q4 | $5.37M | Buy |
+22,043
| New | +$5.37M | 0.08% | 117 |
|
|
2020
Q4 | – | Sell |
-6,920
| Closed | -$1.9M | – | 250 |
|
|
2020
Q3 | $1.9M | Sell |
6,920
-5,547
| -44% | -$1.52M | 0.05% | 119 |
|
|
2020
Q2 | $3.63M | Buy |
+12,467
| New | +$3.63M | 0.1% | 72 |
|
|
2019
Q1 | – | Sell |
-7,325
| Closed | -$1.43M | – | 223 |
|
|
2018
Q4 | $1.43M | Buy |
+7,325
| New | +$1.43M | 0.09% | 84 |
|
|
2017
Q4 | – | Sell |
-5,716
| Closed | -$887K | – | 173 |
|
|
2017
Q3 | $887K | Sell |
5,716
-1,193
| -17% | -$185K | 0.07% | 119 |
|
|
2017
Q2 | $893K | Buy |
+6,909
| New | +$893K | 0.08% | 109 |
|